Association between interleukin 6 gene haplotype and Alzheimer's disease: A Brazilian case-control study

Journal of Alzheimer's Disease

Volumn 36, Issue 4, 2013, Pages 733-738

  Rasmussen, Lucas ^a,c   Delabio, Roger ^b   Horiguchi, Lie ^b   Mizumoto, Igor ^b   Terazaki, Carlos Renato ^b   Mazzotti, Diego ^c   Bertolucci, Paulo Henrique ^c   Pinhel, Marcela Augusta ^d   Souza, Dorotéia ^d   Krieger, Henrique ^e   Kawamata, Carlos ^e   Minett, Thais ^f   Smith, Marilia Cardoso ^c   Payão, Spencer Luiz ^a,b  

^a Hemocentro Famema   (Brazil)

^b FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Association study; case control study; haplotype; interleukin 6 gene; polymorphisms

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 6;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 84881405237     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122407     Document Type: Article

References (36)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191.
2. Capurso C (2011) Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease?. Neurosci Lett 504, 1-3.
3. Wang M, Jia J (2010) The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers. Neurosci Lett 482, 260-263.
4. Hull M, Strauss S, Berger M, Volk B, Bauer J (1996) The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 78, 37-41.
5. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 102, 1369-1376.
6. Han XM, Wang CH, Sima X, Liu SY (2011) Interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis. Neurosci Lett 504, 4-8.
7. Nishimura M, Sakamoto T, Kaji R, Kawakami H (2004) Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett 368, 140-143.
8. He MX, Yang WL, Zhang MM, Lian YJ, Hua HY, Zeng JS, Zhang LR (2010) Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol Sci 31, 165-168.
9. Wang M, Song H, Jia J (2010) Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer's disease in Chinese Han. Brain Res 1327, 1-5.
10. Wojtera M, Sobow T, Kloszewska I, Liberski PP, Brown DR, SikorskaB(2012) Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: Morphometric study and reviewof the literature.Folia Neuropathol 50, 74-84.
11. Llano DA, Li J,Waring JF, Ellis T, Devanarayan V,Witte DG, Lenz RA (2012) Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls Alzheimer Dis Assoc Disord 26, 322-328.
12. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR (2001) Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 59, 532-536.
13. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185, 914-919.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
15. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A (1993) The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43, 2457-2465.
16. Ogilvie EM, Fife MS, Thompson SD, Twine N, Tsoras M, Moroldo M, Fisher SA, Lewis CM, Prieur AM, Glass DN, Woo P (2003) The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: A multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48, 3202-3206.
17. Emery AEH. (1986) Methodology in Medical Genetics: An introduction to statistical methods, Churchill Livingstone.
18. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
19. Fallin D, Schork NJ (2000) Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 67, 947-959.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
21. Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH (2011) Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 77, 212-218.
22. Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F (2010) Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 34, 177-182.
23. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F (2004) Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: Geographic allele and genotype variations in Europe. Exp Gerontol 39, 1567-1573.
24. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, Tornvall P (2004) Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases?. Clin Chem 50, 2136-2140.
25. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68, 930-941.
26. Campisi G, Chiappelli M, De Martinis M, Franco V, Ginaldi L, Guiglia R, Licastro F, Lio D (2009) Pathophysiology of age-related diseases. Immun Ageing 6, 12-.
27. Visentainer JE, Sell AM, da Silva GC, Cavichioli AD, Franceschi DS, Lieber SR, de Souza CA (2008) TNF, IFNG, IL6, IL10 and TGFB1 gene polymorphisms in South and Southeast Brazil. Int J Immunogenet 35, 287-293.
28. Gadelha SR, Alcantara LC, Costa GC, Rios DL, Galvao-Castro B (2005) Ethnic differences in the distribution of interleukin-6 polymorphisms among three Brazilian ethnic groups. Hum Biol 77, 509-514.
29. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R (2002) The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 13, 1645-1647.
30. Faltraco F, Burger K, Zill P, Teipel SJ, Moller HJ, Hampel H, Bondy B, Ackenheil M (2003) Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 51, 578-579.
31. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, ClericiM (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25, 1009-1015.
32. Dai L, Liu D, Guo H, Wang Y, Bai Y (2012) Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: A meta-analysis. J Neurol 259, 414-419.
33. Zintzaras E (2010) Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis. Eur J Epidemiol 25(8), 553-560.
34. Chen SY, Chen TF, Lai LC, Chen JH, Sun Y, Wen LL, Yip PK, Chu YM, ChenYC(2012) Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease. J Neuroinflammation 9, 21.
35. Nibali L, Pelekos G, D'Aiuto F, Chaudhary N, Habeeb R, Ready D, Parkar M, Donos N (2012) Influence of IL-6 haplotypes on clinical and inflammatory response in aggressive periodontitis. Clin Oral Investig 17, 1235-1242.
36. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, Lantigua R, Jimenez-Velazquez IZ, Rogaeva E, St George-Hyslop PH, Mayeux R (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68, 320-328.